Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Honeywell International (NASDAQ:HON) Stock Slips: Is the Reshaped Industrial Giant Still on Track?

Honeywell International Inc. (NASDAQ:HON), the industrial and technology conglomerate, has been undergoing one of the most significant transformations in its history, separating into focused businesses, and the entity now trading under the HON ticker, centered on its automation and technology operations, reported second-quarter 2026 …

Nitish Kishor | 28 August 2026

Cerenome (NASDAQ:CNSY) Stock Gains Ground: Can This Biotech Build on the Move?

Cerenome, Inc. (NASDAQ:CNSY) is a small clinical-stage company focused on cancers of the central nervous system, developing a radiotherapy candidate while commercializing a diagnostic test, and its stock gained ground even amid the challenges facing micro-cap biotechs. Recently rebranded from Plus Therapeutics, the company …

Nitish Kishor | 28 August 2026

Citius Oncology (NASDAQ:CTOR) Is Sliding: Is the Weakness Creating Opportunity or Signaling More Risk?

Citius Oncology, Inc. (NASDAQ:CTOR), a company commercializing an approved cancer immunotherapy, has seen its stock slide even as it reports building commercial momentum for its lead product. The company launched LYMPHIR for a form of lymphoma and has been growing its customer base, leaving …

Nitish Kishor | 28 August 2026

CXApp (NASDAQ:CXAI) Stock Gains Ground: What Could Put It on More Watchlists?

CXApp Inc. (NASDAQ:CXAI), a small software company building an AI-powered workplace-experience platform, saw its stock gain ground as it wins enterprise customers and positions its technology around agentic AI. The company reported first-quarter 2026 results with new enterprise contracts, and its focus on AI-driven …

Nitish Kishor | 28 August 2026

Cognition Therapeutics (NASDAQ:CGTX) Stock Ticks Higher: What Could Put It on More Watchlists?

Cognition Therapeutics, Inc. (NASDAQ:CGTX) is a clinical-stage biotech developing zervimesine (CT1812), an oral drug for neurodegenerative diseases, and the stock ticked higher as the company advances its programs in dementia with Lewy bodies and Alzheimer's disease. With encouraging Phase 2 data and plans for …

Nitish Kishor | 28 August 2026

Chagee Holdings Limited (NASDAQ:CHA) Is Under Pressure: Is This Pullback a Warning or a Contrarian Setup?

Chagee Holdings Limited (NASDAQ:CHA), a fast-growing premium tea-drinks chain that originated in China and listed in the United States, has seen its stock come under pressure as it navigates margin challenges amid a shift in its store model. The company is expanding its network …

Nitish Kishor | 28 August 2026

Altisource Portfolio Solutions (NASDAQ:ASPS) Stock Slips: Is Wall Street Underestimating the Risk?

Altisource Portfolio Solutions S.A. (NASDAQ:ASPS), a provider of services and technology for the mortgage and real-estate industries, has been growing revenue strongly as its diversification strategy gains traction, though the stock slipped. The company reported a sharp revenue increase in the second quarter of …

Nitish Kishor | 28 August 2026

Investors Are Bailing on Aether Holdings (NASDAQ:ATHR): Could This Software and AI Stock Stage a Comeback?

Aether Holdings, Inc. (NASDAQ:ATHR), a small financial-technology company that operates research and analytics platforms for traders and is expanding into AI products, has seen its stock come under heavy pressure amid deep losses and funding concerns. The company owns the SentimenTrader research platform and …

Nitish Kishor | 28 August 2026

Builders FirstSource (NYSE:BLDR) Is Under Pressure: Is This Pullback a Warning or a Contrarian Setup?

Builders FirstSource, Inc. (NYSE:BLDR), the largest U.S. supplier of building products and services to professional homebuilders, has seen its stock come under pressure as a soft housing market weighed on its second-quarter 2026 results and prompted a guidance cut. The company reported lower sales …

Nitish Kishor | 28 August 2026

AirSculpt Technologies (NASDAQ:AIRS) Stock Falls: Can the Rally Still Build From Here?

AirSculpt Technologies, Inc. (NASDAQ:AIRS), a provider of body-contouring and cosmetic procedures through a network of clinics, saw its stock fall after a soft second quarter, as investors weigh the company's differentiated procedures against near-termDemandand profitability pressures. AirSculpt reported a revenue decline and lowered part …

Nitish Kishor | 28 August 2026
Support

Hi! How can we help you today?

Loading…